The World Health Organization (WHO) will meet on Tuesday to consider granting Covaxin, India's indigenous coronavirus vaccine, emergency use approval…
The ICMR collaborated with Bharat Biotech to produce India's first indigenous COVID-19 vaccine. What are the key takeaways from this…
Key Highlights While the CDC in the United States does not allow mixed vaccines in primary series, it is fairly…
Bharat Biotech is on the verge of becoming the second Indian vaccine manufacturer to gain emergency use permission for a…
The Drugs and Comptroller General of India (DCGI) is said to have authorised the administration of Bharat Biotech's Covaxin to…
As India's largest COVID-19 vaccination drive begins, an AIIMS professor claims that the latest trials show that the safety and…
The Indian Council of Medical Research (ICMR) conducted a study on healthcare workers (HCWs) from 11 cities in the country,…
“We are going to start trial for nasal vaccine very soon and I believe it might be a game changer…
Due to a shortage in the market, only one out of every eleven Indians has received the indigenous vaccine, Covaxin,…
Approvals to COVID-19 Covaxin, developed by the Bharat Biotech based in Hyderabad, is expected to be delayed until October 5,…